J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? [Yahoo! Finance]
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash [Yahoo! Finance]
Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves [Yahoo! Finance]
AstraZeneca News On Cancer And Asthma Raises New Questions For Investors [Yahoo! Finance]
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer [Yahoo! Finance]